Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: Review

Tropical Medicine and International Health

Volumn 20, Issue 6, 2015, Pages 707-718

  Steinmann, Peter ^a,b   Stone, Christopher M ^a,b   Sutherland, C Simone ^a,b   Tanner, Marcel ^a,b   Tediosi, Fabrizio ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Control; Elimination; Gambiense HAT; Human African trypanosomiasis; Scenarios; Strategies

Indexed keywords

EFLORNITHINE; FEXINIDAZOLE; MELARSOPROL; NIFURTIMOX; PENTAMIDINE;

DISEASE CONTROL; EPIDEMIOLOGY; ESTIMATION METHOD; FLY; HEALTH CARE;

AFRICAN TRYPANOSOMIASIS; AGGLUTINATION TEST; CEREBROSPINAL FLUID; DISEASE ELIMINATION; FLUORESCENCE MICROSCOPY; INFECTION CONTROL; RAPID TEST; REVIEW; TRYPANOSOMA BRUCEI GAMBIENSE; VECTOR CONTROL; AFRICA; ANIMAL; DISEASE CARRIER; DISEASE ERADICATION; GLOSSINIDAE; HUMAN; NEGLECTED DISEASES; PARASITOLOGY; PHYSIOLOGY; PUBLIC HEALTH; TRYPANOSOMIASIS, AFRICAN;

AFRICA;

GLOSSINA (GENUS); TRYPANOSOMA BRUCEI GAMBIENSE;

AFRICA; ANIMALS; DISEASE ERADICATION; HUMANS; INSECT VECTORS; NEGLECTED DISEASES; PUBLIC HEALTH; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMIASIS, AFRICAN; TSETSE FLIES;

EID: 84928754366     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12483     Document Type: Review

References (54)

1. WHO. Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases. A roadmap for implementation. Executive Summary. World Health Organization: Geneva, 2012, 1-22.
2. Holmes P. First WHO meeting of stakeholders on elimination of gambiense human African trypanosomiasis. PLoS Negl Trop Dis 2014: 8: e3244.
3. Brun R, Blum J, Chappuis F, Burri C. Human African trypanosomiasis. Lancet 2010: 375: 148-159.
4. Malvy D, Chappuis F. Sleeping sickness. Clin Microbiol Infect 2011: 17: 986-995.
5. Welburn SC, Maudlin I, Simarro PP. Controlling sleeping sickness - a review. Parasitology 2009: 136: 1943-1949.
6. Funk S, Nishiura H, Heesterbeek H, Edmunds WJ, Checchi F. Identifying transmission cycles at the human-animal interface: the role of animal reservoirs in maintaining gambiense human african trypanosomiasis. PLoS Comput Biol 2013: 9: e1002855.
7. Simarro PP, Franco JR, Diarra A, Ruiz Postigo JA, Jannin J. Diversity of human African trypanosomiasis epidemiological settings requires fine-tuning control strategies to facilitate disease elimination. Res Rep Trop Med 2013: 4: 1-6.
8. Anonymous. Human African trypanosomiasis (sleeping sickness): epidemiological update. Wkly Epidemiol Rec 2006: 81: 71-80.
9. Simarro PP, Cecchi G, Franco JR et al. Estimating and mapping the population at risk of sleeping sickness. PLoS Negl Trop Dis 2012: 6: e1859.
10. Fèvre EM, Wissmann BV, Welburn SC, Lutumba P. The burden of human African trypanosomiasis. PLoS Negl Trop Dis 2008: 2: e333.
11. Murray CJ, Vos T, Lozano R et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012: 380: 2197-2223.
12. Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012: 380: 2095-2128.
13. Simarro PP, Jannin J, Cattand P. Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Med 2008: 5: e55.
14. Tediosi F, Steinmann P, de Savigny D, Tanner M. Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challenges. PLoS Negl Trop Dis 2013: 7: e2446.
15. Maurice J. New WHO plan targets the demise of sleeping sickness. Lancet 2013: 381: 13-14.
16. WHO. Report of a WHO Meeting on Elimination of African Trypanosomiasis (Trypanosoma Brucei Gambiense). WHO: Geneva, 2013.
17. Courtin F, Jamonneau V, Duvallet G et al. Sleeping sickness in West Africa (1906-2006): changes in spatial repartition and lessons from the past. Trop Med Int Health 2008: 13: 334-344.
18. Hide G. History of sleeping sickness in East Africa. Clin Microbiol Rev 1999: 12: 112-125.
19. Nimmo C. Time to put out the lights on sleeping sickness? Travel Med Infect Dis 2010: 8: 263-268.
20. Steverding D. The history of African trypanosomiasis. Parasit Vectors 2008: 1: 3.
21. Solano P, Torr SJ, Lehane MJ. Is vector control needed to eliminate gambiense human African trypanosomiasis? Front Cell Infect Microbiol 2013: 3: 33.
22. Artzrouni M, Gouteux JP. Control strategies for sleeping sickness in Central Africa: a model-based approach. Trop Med Int Health 1996: 1: 753-764.
23. Laveissière C, Penchenier L. Manuel de Lutte Contre la Maladie du Sommeil. IRD Editions: Paris, 2005.
24. Jamonneau V, Ilboudo H, Kabore J et al. Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal. PLoS Negl Trop Dis 2012: 6: e1691.
25. Bucheton B, MacLeod A, Jamonneau V. Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections. Parasite Immunol 2011: 33: 438-447.
26. Swallow BM, Mulatu W, Leak SGA. Potential demand for a mixed public-private animal health input: evaluation of a pour-on insecticide for controlling tsetse-transmitted trypanosomiasis in Ethiopia. Prev Vet Med 1995: 24: 265-275.
27. WHO. Control and Surveillance of Human African Trypanosomiasis. World Health Organization: Geneva, 2013.
28. Mitashi P, Hasker E, Lejon V et al. Human african trypanosomiasis diagnosis in first-line health services of endemic countries, a systematic review. PLoS Negl Trop Dis 2012: 6: e1919.
29. Simarro PP, Cecchi G, Franco JR et al. Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis. Int J Health Geogr 2014: 13: 4.
30. Palmer JJ, Surur EI, Goch GW et al. Syndromic algorithms for detection of gambiense human African trypanosomiasis in South Sudan. PLoS Negl Trop Dis 2013: 7: e2003.
31. Robays J, Lefevre P, Lutumba P et al. Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo. Trop Med Int Health 2007: 12: 290-298.
32. Hasker E, Lumbala C, Mbo F et al. Health care-seeking behaviour and diagnostic delays for Human African Trypanosomiasis in the Democratic Republic of the Congo. Trop Med Int Health 2011: 16: 869-874.
33. Kagbadouno MS, Camara M, Rouamba J et al. Epidemiology of sleeping sickness in Boffa (Guinea): where are the trypanosomes? PLoS Negl Trop Dis 2012: 6: e1949.
34. Esterhuizen J, Rayaisse JB, Tirados I et al. Improving the cost-effectiveness of visual devices for the control of riverine tsetse flies, the major vectors of human African trypanosomiasis. PLoS Negl Trop Dis 2011: 5: e1257.
35. Lindh JM, Goswami P, Blackburn RS et al. Optimizing the colour and fabric of targets for the control of the tsetse fly Glossina fuscipes fuscipes. PLoS Negl Trop Dis 2012: 6: e1661.
36. Torr SJ, Hargrove JW, Vale GA. Towards a rational policy for dealing with tsetse. Trends Parasitol 2005: 21: 537-541.
37. Simarro PP, Franco J, Diarra A, Postigo JA, Jannin J. Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis. Parasitology 2012: 139: 842-846.
38. FIND. Developing New Diagnostic Tests for Human African Trypanosomiasis. Current Status and Future Plans. Foundation for Innovative New Diagnostics: Geneva, 2013, 1-20.
39. Büscher P, Mertens P, Leclipteux T et al. Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study. Lancet Glob Health 2014: 2: e359-e363.
40. Büscher P, Gilleman Q, Lejon V. Rapid diagnostic test for sleeping sickness. N Engl J Med 2013: 368: 1069-1070.
41. Torreele E, Bourdin Trunz B, Tweats D et al. Fexinidazole - a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness. PLoS Negl Trop Dis 2010: 4: e923.
42. Brun R, Don R, Jacobs RT, Wang MZ, Barrett MP. Development of novel drugs for human African trypanosomiasis. Future Microbiol 2011: 6: 677-691.
43. Mäser P, Wittlin S, Rottmann M et al. Antiparasitic agents: new drugs on the horizon. Curr Opin Pharmacol 2012: 12: 562-566.
44. Jacobs RT, Nare B, Wring SA et al. SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis. PLoS Negl Trop Dis 2011: 5: e1151.
45. Rayaisse JB, Tirados I, Kaba D et al. Prospects for the development of odour baits to control the tsetse flies Glossina tachinoides and G. palpalis s.l. PLoS Negl Trop Dis 2010: 4: e632.
46. Moonen B, Cohen JM, Snow RW et al. Operational strategies to achieve and maintain malaria elimination. Lancet 2010: 376: 1592-1603.
47. Vreysen MJ, Saleh KM, Ali MY et al. Glossina austeni (Diptera: Glossinidae) eradicated on the island of Unguja, Zanzibar, using the sterile insect technique. J Econ Entomol 2000: 93: 123-135.
48. Rogers DJ, Randolph SE. A response to the aim of eradicating tsetse from Africa. Trends Parasitol 2002: 18: 534-536.
49. Simarro PP, Diarra A, Ruiz Postigo JA, Franco JR, Jannin JG. The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward. PLoS Negl Trop Dis 2011: 5: e1007.
50. Checchi F, Filipe JA, Barrett MP, Chandramohan D. The natural progression of Gambiense sleeping sickness: what is the evidence? PLoS Negl Trop Dis 2008: 2: e303.
51. Rogers DJ. A general model for the African trypanosomiases. Parasitology 1988: 97(Pt 1): 193-212.
52. Simarro PP, Cecchi G, Paone M et al. The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geogr 2010: 9: 57.
53. Kelly GC, Hale E, Donald W et al. A high-resolution geospatial surveillance-response system for malaria elimination in Solomon Islands and Vanuatu. Malar J 2013: 12: 108.
54. Simarro PP, Franco JR, Ndongo P et al. The elimination of Trypanosoma brucei gambiense sleeping sickness in the focus of Luba, Bioko Island, Equatorial Guinea. Trop Med Int Health 2006: 11: 636-646.